These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 38574312)
21. Gemcitabine plus cisplatin versus docetaxel plus cisplatin and fluorouracil induction chemotherapy combined with locoregional radiotherapy in de novo metastatic nasopharyngeal carcinoma: A single center prospective phase II clinical trial. Shang K; Li T; Chen Y; Luo X; Wu H; Zhou Y; Song J; Wu W; Li Y; Luo X; Chen X; Gong X; Zhao C; Li Z; Liu L; He Q; Long J; Jin F Oral Oncol; 2024 Dec; 159():107087. PubMed ID: 39488901 [TBL] [Abstract][Full Text] [Related]
22. Assessing the efficacy and tolerability of PET-guided BrECADD versus eBEACOPP in advanced-stage, classical Hodgkin lymphoma (HD21): a randomised, multicentre, parallel, open-label, phase 3 trial. Borchmann P; Ferdinandus J; Schneider G; Moccia A; Greil R; Hertzberg M; Schaub V; Hüttmann A; Keil F; Dierlamm J; Hänel M; Novak U; Meissner J; Zimmermann A; Mathas S; Zijlstra JM; Fosså A; Viardot A; Hertenstein B; Martin S; Giri P; Scholl S; Topp MS; Jung W; Vucinic V; Beck HJ; Kerkhoff A; Unger B; Rank A; Schroers R; Zum Büschenfelde CM; de Wit M; Trautmann-Grill K; Kamper P; Molin D; Kreissl S; Kaul H; von Tresckow B; Borchmann S; Behringer K; Fuchs M; Rosenwald A; Klapper W; Eich HT; Baues C; Zomas A; Hallek M; Dietlein M; Kobe C; Diehl V; ; ; ; ; Lancet; 2024 Jul; 404(10450):341-352. PubMed ID: 38971175 [TBL] [Abstract][Full Text] [Related]
24. The efficacy and safety of the prophylactic application of PEG-rhG-CSF in radiotherapy with weekly concurrent chemotherapy for cervical cancer. Chen H; Ma Y; Wang D; Wu H; Zhang M; Xu Y; Cheng S BMC Cancer; 2024 Nov; 24(1):1405. PubMed ID: 39543536 [TBL] [Abstract][Full Text] [Related]
25. Lamotrigine versus levetiracetam or zonisamide for focal epilepsy and valproate versus levetiracetam for generalised and unclassified epilepsy: two SANAD II non-inferiority RCTs. Marson AG; Burnside G; Appleton R; Smith D; Leach JP; Sills G; Tudur-Smith C; Plumpton CO; Hughes DA; Williamson PR; Baker G; Balabanova S; Taylor C; Brown R; Hindley D; Howell S; Maguire M; Mohanraj R; Smith PE Health Technol Assess; 2021 Dec; 25(75):1-134. PubMed ID: 34931602 [TBL] [Abstract][Full Text] [Related]
26. Postoperative radiotherapy with docetaxel versus cisplatin for high-risk oral squamous cell carcinoma: a randomized phase II trial with exploratory analysis of ITGB1 as a potential predictive biomarker. Jiang W; Chen L; Li R; Li J; Dou S; Ye L; He Y; Tian Z; Yao Y; Zhu G BMC Med; 2024 Jul; 22(1):314. PubMed ID: 39075531 [TBL] [Abstract][Full Text] [Related]
27. Split-Dose Cisplatin in Patients With Locally Advanced or Metastatic Urothelial Carcinoma: A Systematic Literature Review and Network Meta-Analysis. O'Dwyer R; Musat MG; Gulas I; Hubscher E; Moradian H; Guenther S; Kearney M; Sridhar SS Clin Genitourin Cancer; 2024 Dec; 22(6):102176. PubMed ID: 39260094 [TBL] [Abstract][Full Text] [Related]
28. Early high-dose cryoprecipitate to reduce mortality in adult patients with traumatic haemorrhage: the CRYOSTAT-2 RCT with cost-effectiveness analysis. Curry N; Davenport R; Thomas H; Fox E; Lucas J; Evans A; Massou E; Sharma R; Shanmugaranjan S; Rourke C; Newton A; Deary A; Dallas N; Fitzpatrick-Creamer C; Podbielski JM; Wade CE; Edwards A; Benger J; Morris S; Cotton BA; Piercy J; Green L; Brohi K; Stanworth S Health Technol Assess; 2024 Nov; 28(76):1-69. PubMed ID: 39545850 [TBL] [Abstract][Full Text] [Related]
29. Hip Transposition Can Provide Early Walking Function After Periacetabular Tumor Resection: A Multicenter Study. Zhang L; Iwata S; Saito M; Nakagawa M; Tsukushi S; Yoshida S; Gokita T; Ae K; Nakashima S; Watanuki M; Akiyama T Clin Orthop Relat Res; 2023 Dec; 481(12):2406-2416. PubMed ID: 37184605 [TBL] [Abstract][Full Text] [Related]
30. Safety and efficacy of PfSPZ Vaccine against malaria in healthy adults and women anticipating pregnancy in Mali: two randomised, double-blind, placebo-controlled, phase 1 and 2 trials. Diawara H; Healy SA; Mwakingwe-Omari A; Issiaka D; Diallo A; Traore S; Soumbounou IH; Gaoussou S; Zaidi I; Mahamar A; Attaher O; Fried M; Wylie BJ; Mohan R; Doan V; Doritchamou JYA; Dolo A; Morrison RD; Wang J; Hu Z; Rausch KM; Zeguime A; Murshedkar T; Kc N; Sim BKL; Billingsley PF; Richie TL; Hoffman SL; Dicko A; Duffy PE; Lancet Infect Dis; 2024 Dec; 24(12):1366-1382. PubMed ID: 39153490 [TBL] [Abstract][Full Text] [Related]
31. Sequencing of systemic therapy in unresectable hepatocellular carcinoma: A systematic review and Bayesian network meta-analysis of randomized clinical trials. Wang Q; Yu J; Sun X; Li J; Cao S; Han Y; Wang H; Yang Z; Li J; Hu C; Zhang Y; Jin L Crit Rev Oncol Hematol; 2024 Dec; 204():104522. PubMed ID: 39332750 [TBL] [Abstract][Full Text] [Related]
32. Interventions for supporting pregnant women's decision-making about mode of birth after a caesarean. Horey D; Kealy M; Davey MA; Small R; Crowther CA Cochrane Database Syst Rev; 2013 Jul; 2013(7):CD010041. PubMed ID: 23897547 [TBL] [Abstract][Full Text] [Related]
33. Adavosertib in Combination with Olaparib in Patients with Refractory Solid Tumors: An Open-Label, Dose-Finding, and Dose-Expansion Phase Ib Trial. Hamilton EP; Falchook GS; Wang JS; Fu S; Oza AM; Imedio ER; Kumar S; Ottesen L; Mugundu GM; de Bruin EC; O'Connor MJ; Jones SF; Spigel DR; Li BT Target Oncol; 2024 Nov; 19(6):879-892. PubMed ID: 39487373 [TBL] [Abstract][Full Text] [Related]
34. Tobacco Product Use and Associated Factors Among Middle and High School Students - National Youth Tobacco Survey, United States, 2021. Gentzke AS; Wang TW; Cornelius M; Park-Lee E; Ren C; Sawdey MD; Cullen KA; Loretan C; Jamal A; Homa DM MMWR Surveill Summ; 2022 Mar; 71(5):1-29. PubMed ID: 35271557 [TBL] [Abstract][Full Text] [Related]
35. Betibeglogene autotemcel gene therapy in patients with transfusion-dependent, severe genotype β-thalassaemia (HGB-212): a non-randomised, multicentre, single-arm, open-label, single-dose, phase 3 trial. Kwiatkowski JL; Walters MC; Hongeng S; Yannaki E; Kulozik AE; Kunz JB; Sauer MG; Thrasher AJ; Thuret I; Lal A; Tao G; Ali S; Thakar HL; Elliot H; Lodaya A; Lee J; Colvin RA; Locatelli F; Thompson AA Lancet; 2024 Nov; 404(10468):2175-2186. PubMed ID: 39527960 [TBL] [Abstract][Full Text] [Related]
36. Cenerimod, a sphingosine-1-phosphate receptor modulator, versus placebo in patients with moderate-to-severe systemic lupus erythematosus (CARE): an international, double-blind, randomised, placebo-controlled, phase 2 trial. Askanase AD; D'Cruz D; Kalunian K; Merrill JT; Navarra SV; Cahuzac C; Cornelisse P; Murphy MJ; Strasser DS; Trokan L; Berkani O Lancet Rheumatol; 2024 Nov; ():. PubMed ID: 39586304 [TBL] [Abstract][Full Text] [Related]
37. Infliximab for maintenance of medically-induced remission in Crohn's disease. Gordon M; Sinopoulou V; Akobeng AK; Sarian A; Moran GW Cochrane Database Syst Rev; 2024 Feb; 2(2):CD012609. PubMed ID: 38372447 [TBL] [Abstract][Full Text] [Related]
38. Mobile phone text messaging for medication adherence in secondary prevention of cardiovascular disease. Redfern J; Tu Q; Hyun K; Hollings MA; Hafiz N; Zwack C; Free C; Perel P; Chow CK Cochrane Database Syst Rev; 2024 Mar; 3(3):CD011851. PubMed ID: 38533994 [TBL] [Abstract][Full Text] [Related]
39. Treatments for intractable constipation in childhood. Gordon M; Grafton-Clarke C; Rajindrajith S; Benninga MA; Sinopoulou V; Akobeng AK Cochrane Database Syst Rev; 2024 Jun; 6(6):CD014580. PubMed ID: 38895907 [TBL] [Abstract][Full Text] [Related]